PROTON THERAPY, PSMA & FUNCTION PRESERVATION

Advanced Prostate Cancer Care in China

Modern prostate cancer treatment aims for complete cancer cure while strictly preserving urinary continence and sexual function. China operates premier particle therapy centers delivering proton and carbon ion radiation that stop precisely inside the prostate, alongside robotic nerve-sparing surgery and targeted PSMA radioligand therapy for advanced disease.

  • Localized, Locally Advanced, or High-Risk Prostate Cancer
  • Recurrent or Castration-Resistant Prostate Cancer (CRPC)
  • Patients Seeking Complete Organ Preservation & Normal Urinary Control
  • Advanced Carbon Ion & Proton Radiotherapy Centers
  • Da Vinci Robotic Nerve-Sparing Radical Prostatectomy
  • Dedicated Urologic Oncology MDT with Bilingual Navigation

PARTICLE RADIATION, SURGERY & TARGETED HORMONES

Key Prostate Cancer Treatments in China

Proton and carbon ion particle therapy, nerve-sparing robotic surgery, and targeted PSMA radioligand treatments.

Proton & Carbon Ion Radiation

Pinpoint particle beams destroy prostate cancer cells with sub-millimeter precision, causing virtually zero radiation damage to the rectum and bladder.
Learn More

Robotic Nerve-Sparing Surgery

Da Vinci robotic surgery that meticulously protects the delicate nerves responsible for urinary continence and erectile function.
Learn More

Targeted PSMA Radioligand Therapy

Precision molecular therapy targeting PSMA receptors on prostate cancer cells to treat widespread or metastatic disease.
Learn More

WHY CHOOSE US

Why Choose China Cancer Help for Prostate Cancer Care

A patient-first clinical pathway connecting international men directly with premier urologic oncology centers in China.

China’s national particle radiation centers offer unmatched precision for prostate cancer. Carbon ion beams possess high relative biological effectiveness (RBE), delivering intense double-strand DNA damage to prostate tumors while the steep Bragg peak prevents radiation from touching the rectum and bladder base, virtually eliminating urinary incontinence and rectal bleeding.

For surgical candidates, top academic urology centers perform thousands of robotic radical prostatectomies with precise neurovascular bundle preservation. Transparent public hospital billing and personal bilingual case managers ensure an effortless care experience.

CASE EVALUATION PATHWAY

A Structured Pathway from Records to Care

A transparent, four-stage continuum connecting preliminary clinical evaluation to official hospital acceptance, specialized inpatient care, and ongoing continuity.

01. Submit Records Online

Upload pathology reports, biomarker NGS profiles, and imaging scans through our confidential clinical intake portal.

02. Remote MDT Review

National Clinical Research Center oncology boards evaluate eligibility, target expression, and formulate a customized protocol.

03. Visa & Admission

Receive official hospital medical invitation letters, transparent pricing schedules, and expedited department admission.

04. Treatment & Follow-up

Inpatient cellular or particle therapy in ISO-GMP cleanrooms with dedicated bilingual escorts and remote post-discharge care.

PATIENT FAQS

Frequently Asked Questions

Key clinical, financial, and logistical insights for international Prostate Cancer patients considering advanced treatment in China.

Because particle beams stop inside the prostate without exiting into the rectum or bladder, the risk of long-term rectal bleeding or permanent urinary incontinence is drastically lower.
Yes. Both particle beam radiation and robotic nerve-sparing surgery are specifically designed to safeguard the neurovascular bundles controlling continence and potency.
Patients have access to advanced PSMA targeted radioligand therapies, second-generation anti-androgens, and PARP inhibitors for genetic mutations.
Hypofractionated carbon ion protocols can complete treatment in as few as 12 to 16 treatment sessions, significantly shorter than conventional 40-session photon radiotherapy.

UROLOGIC ONCOLOGY CLINICAL ASSESSMENT

Request a Confidential Case Review for Prostate Cancer

Submit your PSA test history, prostate MRI scans, and biopsy Gleason score for a comprehensive evaluation by our senior urology board.

    Prostate Cancer